High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Clinical trial NCT06812871 · COMPLETED
Trial details
- NCT number
- NCT06812871
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-03-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.